710 related articles for article (PubMed ID: 26260307)
1. Inflammation and plaque vulnerability.
Hansson GK; Libby P; Tabas I
J Intern Med; 2015 Nov; 278(5):483-93. PubMed ID: 26260307
[TBL] [Abstract][Full Text] [Related]
2. Thrombosis formation on atherosclerotic lesions and plaque rupture.
Badimon L; Vilahur G
J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
[TBL] [Abstract][Full Text] [Related]
3. [Pathology of AtheroThrombosIS (ATIS)].
Ueda M
Drugs; 2010 Nov; 70 Suppl 1():3-8. PubMed ID: 20977286
[TBL] [Abstract][Full Text] [Related]
4. Carotid plaque vulnerability: a positive feedback between hemodynamic and biochemical mechanisms.
Cicha I; Wörner A; Urschel K; Beronov K; Goppelt-Struebe M; Verhoeven E; Daniel WG; Garlichs CD
Stroke; 2011 Dec; 42(12):3502-10. PubMed ID: 21998063
[TBL] [Abstract][Full Text] [Related]
5. Endothelial erosion of plaques as a substrate for coronary thrombosis.
White SJ; Newby AC; Johnson TW
Thromb Haemost; 2016 Mar; 115(3):509-19. PubMed ID: 26791872
[TBL] [Abstract][Full Text] [Related]
6. Carotid atherosclerosis. Immunocytochemical analysis of the vascular and cellular composition in endarterectomies.
Milei J; Parodi JC; Fernandez Alonso G; Barone A; Beigelman R; Ferreira LM; Arrigoni G; Matturri L
Cardiologia; 1996 Jun; 41(6):535-42. PubMed ID: 8766416
[TBL] [Abstract][Full Text] [Related]
7. Platelet biology and function: plaque erosion vs. rupture.
Baaten CCFMJ; Nagy M; Bergmeier W; Spronk HMH; van der Meijden PEJ
Eur Heart J; 2024 Jan; 45(1):18-31. PubMed ID: 37940193
[TBL] [Abstract][Full Text] [Related]
8. From vulnerable plaque to atherothrombosis.
Thim T; Hagensen MK; Bentzon JF; Falk E
J Intern Med; 2008 May; 263(5):506-16. PubMed ID: 18410594
[TBL] [Abstract][Full Text] [Related]
9. The role of damage- and pathogen-associated molecular patterns in inflammation-mediated vulnerability of atherosclerotic plaques.
Rai V; Agrawal DK
Can J Physiol Pharmacol; 2017 Oct; 95(10):1245-1253. PubMed ID: 28746820
[TBL] [Abstract][Full Text] [Related]
10. Molecular imaging of matrix metalloproteinases in atherosclerotic plaques.
Lenglet S; Thomas A; Chaurand P; Galan K; Mach F; Montecucco F
Thromb Haemost; 2012 Mar; 107(3):409-16. PubMed ID: 22274652
[TBL] [Abstract][Full Text] [Related]
11. Regions of low endothelial shear stress colocalize with positive vascular remodeling and atherosclerotic plaque disruption: an in vivo magnetic resonance imaging study.
Phinikaridou A; Hua N; Pham T; Hamilton JA
Circ Cardiovasc Imaging; 2013 Mar; 6(2):302-10. PubMed ID: 23357244
[TBL] [Abstract][Full Text] [Related]
12. Role of inflammation in atherosclerosis.
Spagnoli LG; Bonanno E; Sangiorgi G; Mauriello A
J Nucl Med; 2007 Nov; 48(11):1800-15. PubMed ID: 17942804
[TBL] [Abstract][Full Text] [Related]
13. Update on acute coronary syndromes: the pathologists' view.
Falk E; Nakano M; Bentzon JF; Finn AV; Virmani R
Eur Heart J; 2013 Mar; 34(10):719-28. PubMed ID: 23242196
[TBL] [Abstract][Full Text] [Related]
14. Impaired fibrous repair: a possible contributor to atherosclerotic plaque vulnerability in patients with type II diabetes.
Edsfeldt A; Gonçalves I; Grufman H; Nitulescu M; Dunér P; Bengtsson E; Mollet IG; Persson A; Nilsson M; Orho-Melander M; Melander O; Björkbacka H; Nilsson J
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2143-50. PubMed ID: 25035341
[TBL] [Abstract][Full Text] [Related]
15. How do we prevent the vulnerable atherosclerotic plaque from rupturing? Insights from in vivo assessments of plaque, vascular remodeling, and local endothelial shear stress.
Andreou I; Antoniadis AP; Shishido K; Papafaklis MI; Koskinas KC; Chatzizisis YS; Coskun AU; Edelman ER; Feldman CL; Stone PH
J Cardiovasc Pharmacol Ther; 2015 May; 20(3):261-75. PubMed ID: 25336461
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and plaque vulnerability.
Shah PK
Cardiovasc Drugs Ther; 2009 Feb; 23(1):31-40. PubMed ID: 18949542
[TBL] [Abstract][Full Text] [Related]
17. Mast cells in vulnerable coronary plaques: potential mechanisms linking mast cell activation to plaque erosion and rupture.
Lindstedt KA; Kovanen PT
Curr Opin Lipidol; 2004 Oct; 15(5):567-73. PubMed ID: 15361793
[TBL] [Abstract][Full Text] [Related]
18. Mast cells: multipotent local effector cells in atherothrombosis.
Kovanen PT
Immunol Rev; 2007 Jun; 217():105-22. PubMed ID: 17498055
[TBL] [Abstract][Full Text] [Related]
19. Role of sirtuins in attenuating plaque vulnerability in atherosclerosis.
Velpuri P; Rai V; Agrawal DK
Mol Cell Biochem; 2024 Jan; 479(1):51-62. PubMed ID: 36952068
[TBL] [Abstract][Full Text] [Related]
20. Microvascular endoglin (CD105) expression correlates with tissue markers for atherosclerotic plaque vulnerability in an ageing population with multivessel coronary artery disease.
Li X; van der Meer JJ; van der Loos CM; Ploegmakers HJ; de Boer OJ; de Winter RJ; van der Wal AC
Histopathology; 2012 Jul; 61(1):88-97. PubMed ID: 22463585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
